These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 7846057)

  • 1. CTLA4 mediates antigen-specific apoptosis of human T cells.
    Gribben JG; Freeman GJ; Boussiotis VA; Rennert P; Jellis CL; Greenfield E; Barber M; Restivo VA; Ke X; Gray GS
    Proc Natl Acad Sci U S A; 1995 Jan; 92(3):811-5. PubMed ID: 7846057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of T cell activation by CD28 and CTLA4.
    Noel PJ; Boise LH; Thompson CB
    Adv Exp Med Biol; 1996; 406():209-17. PubMed ID: 8910687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells.
    Krummel MF; Allison JP
    J Exp Med; 1996 Jun; 183(6):2533-40. PubMed ID: 8676074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CTLA-4 ligation blocks CD28-dependent T cell activation.
    Walunas TL; Bakker CY; Bluestone JA
    J Exp Med; 1996 Jun; 183(6):2541-50. PubMed ID: 8676075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic T lymphocyte antigen-4 accumulation in the immunological synapse is regulated by TCR signal strength.
    Egen JG; Allison JP
    Immunity; 2002 Jan; 16(1):23-35. PubMed ID: 11825563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptotic signaling in lymphocytes.
    Rudin CM; Van Dongen J; Thompson CB
    Curr Opin Hematol; 1996 Jan; 3(1):35-40. PubMed ID: 9372049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD28: a signalling perspective.
    Ward SG
    Biochem J; 1996 Sep; 318 ( Pt 2)(Pt 2):361-77. PubMed ID: 8809021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy.
    Wells AD; Walsh MC; Bluestone JA; Turka LA
    J Clin Invest; 2001 Sep; 108(6):895-903. PubMed ID: 11560959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of CD80, CD86, and CTLA4 on mouse CD4(+) T lymphocytes in enhancing cell-cycle progression and survival after activation with PMA and ionomycin.
    Mukherjee S; Maiti PK; Nandi D
    J Leukoc Biol; 2002 Nov; 72(5):921-31. PubMed ID: 12429713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of susceptibility to HIV-1 infection by the cytotoxic T lymphocyte antigen 4 costimulatory molecule.
    Riley JL; Schlienger K; Blair PJ; Carreno B; Craighead N; Kim D; Carroll RG; June CH
    J Exp Med; 2000 Jun; 191(11):1987-97. PubMed ID: 10839813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated human B lymphocytes express three CTLA-4 counterreceptors that costimulate T-cell activation.
    Boussiotis VA; Freeman GJ; Gribben JG; Daley J; Gray G; Nadler LM
    Proc Natl Acad Sci U S A; 1993 Dec; 90(23):11059-63. PubMed ID: 7504293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [CD28/B7 costimulating signal and its clinical significance].
    Qu MH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Jun; 10(3):265-7. PubMed ID: 12513801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B7-dependent T-cell costimulation in mice lacking CD28 and CTLA4.
    Mandelbrot DA; Oosterwegel MA; Shimizu K; Yamada A; Freeman GJ; Mitchell RN; Sayegh MH; Sharpe AH
    J Clin Invest; 2001 Apr; 107(7):881-7. PubMed ID: 11285307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and applications of surface-linked single chain antibodies against T-cell antigens.
    Griffin MD; Holman PO; Tang Q; Ashourian N; Korthäuer U; Kranz DM; Bluestone JA
    J Immunol Methods; 2001 Feb; 248(1-2):77-90. PubMed ID: 11223070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of lymphocytes by BAT and anti CTLA-4: comparison of binding to T and B cells.
    Raiter A; Novogrodsky A; Hardy B
    Immunol Lett; 1999 Aug; 69(2):247-51. PubMed ID: 10482359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD85/LIR-1/ILT2 and CD152 (cytotoxic T lymphocyte antigen 4) inhibitory molecules down-regulate the cytolytic activity of human CD4+ T-cell clones specific for Mycobacterium tuberculosis.
    Merlo A; Saverino D; Tenca C; Grossi CE; Bruno S; Ciccone E
    Infect Immun; 2001 Oct; 69(10):6022-9. PubMed ID: 11553539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of CTLA-4 in the regulation of T cell immune responses.
    McCoy KD; Le Gros G
    Immunol Cell Biol; 1999 Feb; 77(1):1-10. PubMed ID: 10101680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of CTLA-4 in induction and maintenance of peripheral T cell tolerance.
    Eagar TN; Karandikar NJ; Bluestone JA; Miller SD
    Eur J Immunol; 2002 Apr; 32(4):972-81. PubMed ID: 11920563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CTLA-4 and CD28 mRNA are coexpressed in most T cells after activation. Expression of CTLA-4 and CD28 mRNA does not correlate with the pattern of lymphokine production.
    Freeman GJ; Lombard DB; Gimmi CD; Brod SA; Lee K; Laning JC; Hafler DA; Dorf ME; Gray GS; Reiser H
    J Immunol; 1992 Dec; 149(12):3795-801. PubMed ID: 1281186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexamethasone enhances CTLA-4 expression during T cell activation.
    Xia M; Gasser J; Feige U
    Cell Mol Life Sci; 1999 Sep; 55(12):1649-56. PubMed ID: 10526580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.